Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Chronic Renal Failure

Free Subscription Articles published in J Am Soc Nephrol Retrieve available abstracts of 115 articles: HTML format

Single Articles

November 2023
1. PINTER J, Smyth B, Stuard S, Jardine M, et al
   Impact of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort.
   J Am Soc Nephrol. 2023 Nov 15. doi: 10.1681/ASN.0000000000000262.
   PubMed     Abstract available
   
   
   October 2023
2. 
   Erratum: Tubular and Glomerular Size by Cortex Depth as Predictors for Progressive Chronic Kidney Disease after Radical Nephrectomy for Tumor.
   J Am Soc Nephrol. 2023 Oct 18. doi: 10.1681/ASN.0000000000000228.
   PubMed    
   
   
   
3. KU E, Copeland T, McCulloch CE, Freise C, et al
   Peritoneal dialysis catheter complications after insertion by surgeons, radiologists, or nephrologists.
   J Am Soc Nephrol. 2023 Oct 17. doi: 10.1681/ASN.0000000000000250.
   PubMed     Abstract available
   
   
   
4. DELGADO C, Powe NR, Chertow GM, Grimes B, et al
   Muscle Mass and Serum Creatinine Concentration by Race and Ethnicity Among Hemodialysis Patients.
   J Am Soc Nephrol. 2023 Oct 12. doi: 10.1681/ASN.0000000000000240.
   PubMed     Abstract available
   
   
   
5. DAHL N, Bloom MS, Chebib FT, Clark D, et al
   The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults With Chronic Kidney Disease.
   J Am Soc Nephrol. 2023 Oct 5. doi: 10.1681/ASN.0000000000000249.
   PubMed     Abstract available
   
   
   
6. SCHOLD JD, Huml AM, Husain SA, Mohan S, et al
   Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation.
   J Am Soc Nephrol. 2023;34:1615-1617.
   PubMed    
   
   
   September 2023
7. MCCOY IE, Weinhandl E, Hussein W, Hsu CY, et al
   Initial Management and Potential Opportunities to Deprescribe Dialysis Among AKI-D Patients after Hospital Discharge.
   J Am Soc Nephrol. 2023 Sep 28. doi: 10.1681/ASN.0000000000000225.
   PubMed    
   
   
   
8. DAVIS OM, Kore R, Moore A, Ware J, et al
   Platelet Count and Platelet Volume in Patients with Chronic Kidney Disease.
   J Am Soc Nephrol. 2023 Sep 6. doi: 10.1681/ASN.0000000000000220.
   PubMed    
   
   
   
9. ALLON M, Al-Balas A, Young CJ, Cutter GR, et al
   Effects of a More Selective Arteriovenous Fistula Strategy on Vascular Access Outcomes.
   J Am Soc Nephrol. 2023;34:1589-1600.
   PubMed     Abstract available
   
   
   August 2023
10. MEYER TW, Bargman JM
    The Removal of Uremic Solutes by Peritoneal Dialysis.
    J Am Soc Nephrol. 2023 Aug 9. doi: 10.1681/ASN.0000000000000211.
    PubMed     Abstract available
    
    
    July 2023
11. TIAN FF, Hall YN, Griffin S, Kranze T, et al
    The Complex Patchwork of Transportation for In-Center Hemodialysis.
    J Am Soc Nephrol. 2023 Jul 27. doi: 10.1681/ASN.0000000000000193.
    PubMed     Abstract available
    
    
    
12. WANG H, Liu X, Song L, Yang W, et al
    Dysfunctional Coupling of Cerebral Blood flow and Susceptibility Value in the Bilateral Hippocampus is Associated with Cognitive Decline in Non-dialysis Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 Jul 20. doi: 10.1681/ASN.0000000000000185.
    PubMed     Abstract available
    
    
    
13. NATH KA
    Does the Primacy of the Fistula Still Prevail in an Aging Hemodialysis Population?
    J Am Soc Nephrol. 2023 Jul 17. doi: 10.1681/ASN.0000000000000183.
    PubMed    
    
    
    
14. DENIC A, Gaddam M, Moustafa A, Mullan AF, et al
    Tubular and Glomerular Size by Cortex Depth as Predictors of Progressive Chronic Kidney Disease after Radical Nephrectomy for Tumor.
    J Am Soc Nephrol. 2023 Jul 11. doi: 10.1681/ASN.0000000000000180.
    PubMed     Abstract available
    
    
    
15. ZHU Z, Rosenkranz KA, Kusunoki Y, Li C, et al
    Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.
    J Am Soc Nephrol. 2023 Jul 10. doi: 10.1681/ASN.0000000000000186.
    PubMed     Abstract available
    
    
    
16. GUPTA A, Bansal A, Young K, Gautam A, et al
    Blood brain barrier permeability in end stage kidney disease- A proof of concept study.
    J Am Soc Nephrol. 2023 Jul 4. doi: 10.1681/ASN.0000000000000167.
    PubMed    
    
    
    June 2023
17. PACKER M
    Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 Jun 21. doi: 10.1681/ASN.0000000000000177.
    PubMed     Abstract available
    
    
    
18. WYLD ML, De La Mata NL, Hedley J, Kim S, et al
    Life Years Lost in Children with Kidney Failure: A Binational Cohort Study with Multistate Probabilities of Death and Life Expectancy.
    J Am Soc Nephrol. 2023;34:1057-1068.
    PubMed     Abstract available
    
    
    
19. ROBINSON-COHEN C, Triozzi JL, Rowan B, He J, et al
    Genome-Wide Association Study of Chronic Kidney Disease Progression.
    J Am Soc Nephrol. 2023 Jun 1. doi: 10.1681/ASN.0000000000000170.
    PubMed     Abstract available
    
    
    
20. KU E, McCulloch CE, Sarnak MJ
    Authors' Reply: A Specific Target BP in Chronic Kidney Disease Remains Unclear.
    J Am Soc Nephrol. 2023;34:1122.
    PubMed    
    
    
    
21. YAMADA T, Puttarajappa CM, Kovesdy CP, Obi Y, et al
    A Specific Target BP in Chronic Kidney Disease Remains Unclear.
    J Am Soc Nephrol. 2023;34:1121-1122.
    PubMed    
    
    
    May 2023
22. ASGHAR MS, Denic A, Mullan AF, Moustafa A, et al
    Age-Based versus Young-Adult Thresholds for Nephrosclerosis on Kidney Biopsy and Prognostic Implications for Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 May 31. doi: 10.1681/ASN.0000000000000171.
    PubMed     Abstract available
    
    
    
23. HIRT-MINKOWSKI P, Handschin J, Stampf S, Hopfer H, et al
    Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine.
    J Am Soc Nephrol. 2023 May 25. doi: 10.1681/ASN.0000000000000160.
    PubMed     Abstract available
    
    
    
24. GHASEMI S, Wuttke M
    Genetic Association Analysis of Chronic Kidney Disease Progression in a Small Korean Cohort Study.
    J Am Soc Nephrol. 2023;34:729-731.
    PubMed    
    
    
    April 2023
25. KELLY DM
    Dialysis on the Mind: The Evolution of Hemodialysis-Related Acute Brain Injury.
    J Am Soc Nephrol. 2023 Apr 27. doi: 10.1681/ASN.0000000000000144.
    PubMed    
    
    
    
26. CERVANTES L, Rizzolo K, Tummalapalli SL, Powe NR, et al
    Economic Impact of a Change in Medicaid Coverage Policy for Dialysis Care of Undocumented Immigrants.
    J Am Soc Nephrol. 2023 Apr 5. doi: 10.1681/ASN.0000000000000139.
    PubMed    
    
    
    
27. YAU K, Jeyakumar N, Kang Y, Dixon SN, et al
    Association of Primary versus Rotating Nephrologist Model of Care in Hemodialysis Programs with Patient Outcomes.
    J Am Soc Nephrol. 2023 Apr 5. doi: 10.1681/ASN.0000000000000133.
    PubMed    
    
    
    
28. DOUTE M, Sannier A, Even G, Tran TT, et al
    Thrombopoietin-dependent Myelo-megakaryopoiesis Fuels Thromboinflammation and Worsens Antibody-mediated Chronic Renal Microvascular Injury.
    J Am Soc Nephrol. 2023 Apr 5. doi: 10.1681/ASN.0000000000000127.
    PubMed     Abstract available
    
    
    March 2023
29. DENIC A, Mullan AF, Alexander MP, Wilson LD, et al
    An Improved Method for Estimating Nephron Number and Association of the Resulting Nephron Number Estimates with Chronic Kidney Disease Outcomes.
    J Am Soc Nephrol. 2023 Mar 23. doi: 10.1681/ASN.0000000000000124.
    PubMed     Abstract available
    
    
    
30. FLYTHE JE, Forfang D, Harris RC, Wood D, et al
    Risk Tolerance in the Setting of Wearable Dialysis Devices: A Patient Preference Study Using the Threshold Technique.
    J Am Soc Nephrol. 2023 Mar 15. doi: 10.1681/ASN.0000000000000120.
    PubMed    
    
    
    
31. ANAZODO UC, Wong DY, Theberge J, Dacey M, et al
    Hemodialysis-Related Acute Brain Injury Demonstrated by Application of Intradialytic Magnetic Resonance Imaging and Spectroscopy.
    J Am Soc Nephrol. 2023 Mar 9. doi: 10.1681/ASN.0000000000000105.
    PubMed     Abstract available
    
    
    February 2023
32. MALIHA G, Weinhandl ED, Reddy YNV
    Deprescribing the Kt/V Target for Peritoneal Dialysis in the US: The Path Toward Adopting International Standards for Dialysis Adequacy.
    J Am Soc Nephrol. 2023 Feb 14. doi: 10.1681/ASN.0000000000000101.
    PubMed    
    
    
    
33. BRESSENDORFF I, Hansen D, Schou M, Kragelund C, et al
    The Effect of Magnesium Supplementation on Vascular Calcification in Chronic Kidney Disease: A Randomized Clinical Trial (MAGiCAL-CKD).
    J Am Soc Nephrol. 2023 Feb 2. doi: 10.1681/ASN.0000000000000092.
    PubMed     Abstract available
    
    
    
34. EPSTEIN RL, Pramanick T, Baptiste D, Buzzee B, et al
    A Microsimulation Study of the Cost-Effectiveness of Hepatitis C Virus Screening Frequencies in Hemodialysis Centers.
    J Am Soc Nephrol. 2023;34:205-219.
    PubMed     Abstract available
    
    
    
35. ZHENG H, Lin E
    How Frequently Should We Screen for Hepatitis C in US Hemodialysis Centers? Evaluating the Cost-Effectiveness of Different Strategies.
    J Am Soc Nephrol. 2023;34:193-194.
    PubMed    
    
    
    January 2023
36. CORMICAN S, Negi N, Naicker SD, Islam MN, et al
    Chronic Kidney Disease Is Characterized by Expansion of a Distinct Proinflammatory Intermediate Monocyte Subtype and by Increased Monocyte Adhesion to Endothelial Cells.
    J Am Soc Nephrol. 2023 Jan 26. doi: 10.1681/ASN.0000000000000083.
    PubMed     Abstract available
    
    
    
37. KALIM S, Zhao S, Tang M, Rhee EP, et al
    Protein Carbamylation and the Risk of End-Stage Kidney Disease in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 Jan 21. doi: 10.1681/ASN.0000000000000078.
    PubMed     Abstract available
    
    
    
38. KATTAH AG, Butler CR
    The nephrologist's role in supporting people with chronic kidney disease and unplanned pregnancy post-Dobbs.
    J Am Soc Nephrol. 2023 Jan 17. doi: 10.1681/ASN.0000000000000081.
    PubMed    
    
    
    
39. GUTHRIE L, Sonnenburg JL, Fischbach MA, Meyer TW, et al
    A Limited Effect of Chronic Renal Insufficiency on the Colon Microbiome.
    J Am Soc Nephrol. 2023 Jan 13. doi: 10.1681/ASN.0000000000000064.
    PubMed    
    
    
    
40. WEISBORD SD, Mor MK, Hochheiser H, Kim N, et al
    Utilization and Outcomes of Clinically Indicated Invasive Cardiac Care in Veterans with Acute Coronary Syndrome and Chronic Kidney Disease.
    J Am Soc Nephrol. 2023 Jan 5. doi: 10.1681/ASN.0000000000000067.
    PubMed     Abstract available
    
    
    
41. HAN M, Moon S, Lee S, Kim K, et al
    Novel Genetic Variants Associated with Chronic Kidney Disease Progression.
    J Am Soc Nephrol. 2023 Jan 5. doi: 10.1681/ASN.0000000000000066.
    PubMed     Abstract available
    
    
    December 2022
42. ROSALES IA, Mahowald GK, Tomaszewski K, Hotta K, et al
    Banff Human Organ Transplant Transcripts Correlate with Renal Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection.
    J Am Soc Nephrol. 2022;33:2306-2319.
    PubMed     Abstract available
    
    
    November 2022
43. GINSBERG C, Miller LM, Ofsthun N, Dalrymple LS, et al
    Differences in Phosphate and Parathyroid Hormone Concentrations over the Day among Patients on Hemodialysis.
    J Am Soc Nephrol. 2022;33:2087-2093.
    PubMed     Abstract available
    
    
    October 2022
44. VERBITSKY M, Krishnamurthy S, Krithivasan P, Hughes D, et al
    Genomic Disorders in Chronic Kidney Disease Across the Lifespan.
    J Am Soc Nephrol. 2022 Oct 27. pii: ASN.2022060725. doi: 10.1681/ASN.2022060725.
    PubMed     Abstract available
    
    
    
45. SHUKLA A, Cavanaugh K, Wadhwa A, Crowley S, et al
    Basic Requirements for Improving Home Dialysis Utilization: Specialty Nephrology Care and Pre-End Stage Kidney Disease Education.
    J Am Soc Nephrol. 2022 Oct 25. pii: ASN.2022060685. doi: 10.1681/ASN.2022060685.
    PubMed    
    
    
    
46. TUMMALAPALLI SL, Lin E
    Is Home Dialysis the Way Forward for Medicare? Assessing Potential Cost Savings Associated with Peritoneal Dialysis.
    J Am Soc Nephrol. 2022 Oct 12. pii: ASN.2022091017. doi: 10.1681/ASN.2022091017.
    PubMed    
    
    
    
47. SHARIF A
    Targeting the Right Metrics for Kidney Transplantation Success.
    J Am Soc Nephrol. 2022 Oct 12. pii: ASN.2022080872. doi: 10.1681/ASN.2022080872.
    PubMed    
    
    
    
48. STRUTHERS SA, Kribs Z, Butler CR
    Policy and Kidney Community Engagement to Advance toward Greener Kidney Care.
    J Am Soc Nephrol. 2022;33:1811-1813.
    PubMed    
    
    
    September 2022
49. BISSONNETTE MLZ, Riazy M, Cunningham AM, Gill JS, et al
    A Step toward Understanding the Story Behind the Pictures: Molecular Diagnostics and the Banff Classification of Renal Allograft Pathology.
    J Am Soc Nephrol. 2022 Sep 28. pii: ASN.2022070847. doi: 10.1681/ASN.2022070847.
    PubMed    
    
    
    
50. BUTLER CR, Wachterman MW, O'Hare AM
    Concurrent Hospice and Dialysis: Proof of Concept.
    J Am Soc Nephrol. 2022 Sep 12. pii: ASN.2022080919. doi: 10.1681/ASN.2022080919.
    PubMed    
    
    
    
51. HASSAN A, Pollak YE, Kilav-Levin R, Silver J, et al
    Kidney Failure Alters Parathyroid Pin1 Phosphorylation and Parathyroid Hormone mRNA-Binding Proteins, Leading to Secondary Hyperparathyroidism.
    J Am Soc Nephrol. 2022;33:1677-1693.
    PubMed     Abstract available
    
    
    
52. GUEDES M, Pecoits-Filho R
    Searching for the Risk-Benefit Profile of Higher Potassium Intake in CKD: Primum Non Nocere.
    J Am Soc Nephrol. 2022;33:1633-1635.
    PubMed    
    
    
    
53. MENDU ML, Bieber SD, Watnick SG, Weiner DE, et al
    The Advancing American Kidney Health Initiative: Do Not Let 80% Distract Us from the Fact that We Can Do Better.
    J Am Soc Nephrol. 2022;33:1798-1799.
    PubMed    
    
    
    
54. QUINN RR, Lam NN, Ravani P, Oliver MJ, et al
    Authors' Reply: "The Advancing American Kidney Health Initiative: The Challenge of Overcoming the Status Quo" and "The Advancing American Kidney Health Initiative: Do Not Let 80% Distract Us from the Fact that We Can Do Better".
    J Am Soc Nephrol. 2022;33:1800-1801.
    PubMed    
    
    
    
55. CONWAY PT, Gedney N, Roy S, Fissell WH, et al
    The Advancing American Kidney Health Initiative: The Challenge of Overcoming the Status Quo.
    J Am Soc Nephrol. 2022;33:1797-1798.
    PubMed    
    
    
    August 2022
56. ROSTOKER G, Issad B
    Financial Barriers to the Optimal Use of Peritoneal Dialysis in France and Europe, as in the United States.
    J Am Soc Nephrol. 2022 Aug 30. pii: ASN.2022070839. doi: 10.1681/ASN.2022070839.
    PubMed    
    
    
    
57. BERGLING K, Martus G, Oberg C
    Phloretin Improves Ultrafiltration and Reduces Glucose Absorption during Peritoneal Dialysis in Rats.
    J Am Soc Nephrol. 2022 Aug 19. pii: ASN.2022040474. doi: 10.1681/ASN.2022040474.
    PubMed     Abstract available
    
    
    
58. HOLLE J, Bartolomaeus H, Lober U, Behrens F, et al
    Inflammation in Children with Chronic Kidney Disease Linked to Gut Dysbiosis and Metabolite Imbalance.
    J Am Soc Nephrol. 2022 Aug 19. pii: ASN.2022030378. doi: 10.1681/ASN.2022030378.
    PubMed     Abstract available
    
    
    
59. KAPLAN JM, Niu J, Ho V, Winkelmayer WC, et al
    A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis.
    J Am Soc Nephrol. 2022 Aug 18. pii: ASN.2022020221. doi: 10.1681/ASN.2022020221.
    PubMed     Abstract available
    
    
    
60. JONGS N, Chertow G, Greene T, McMurray J, et al
    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Aug 17. pii: ASN.2022030306. doi: 10.1681/ASN.2022030306.
    PubMed     Abstract available
    
    
    
61. MONTEZ-RATH ME, Garcia P, Han J, Cadden L, et al
    SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses.
    J Am Soc Nephrol. 2022 Aug 16. pii: ASN.2022040504. doi: 10.1681/ASN.2022040504.
    PubMed     Abstract available
    
    
    
62. MALIHA G, Glickman JD, McCoy MS
    Ensuring Equitable Access to Dialysis: The Medicare Secondary Payer Act in Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita, Inc.
    J Am Soc Nephrol. 2022 Aug 3. pii: ASN.2022020224. doi: 10.1681/ASN.2022020224.
    PubMed    
    
    
    July 2022
63. TERKER A, Saritas T, McDonough A
    The Highs and Lows of Potassium Intake in Chronic Kidney Disease - Does One Size Fit All?
    J Am Soc Nephrol. 2022 Jul 19. pii: ASN.2022070743. doi: 10.1681/ASN.2022070743.
    PubMed    
    
    
    
64. BARRACLOUGH KA, McAlister S
    Assessing the Carbon Footprint of Hemodialysis: A First Step Toward Environmentally Sustainable Kidney Care.
    J Am Soc Nephrol. 2022 Jul 15. pii: ASN.2022060661. doi: 10.1681/ASN.2022060661.
    PubMed    
    
    
    
65. BLUM MF, Feng Y, Anderson GB, Segev DL, et al
    Hurricanes and Mortality among Patients Receiving Dialysis.
    J Am Soc Nephrol. 2022 Jul 14. pii: ASN.2021111520. doi: 10.1681/ASN.2021111520.
    PubMed     Abstract available
    
    
    
66. ERNECOFF N, Bursic A, Motter E, Lagnese K, et al
    Description and Outcomes of an Innovative Concurrent Hospice-Dialysis Program.
    J Am Soc Nephrol. 2022 Jul 12. pii: ASN.2022010064. doi: 10.1681/ASN.2022010064.
    PubMed     Abstract available
    
    
    
67. RICHERSON WT, Schmit BD, Wolfgram DF
    The Relationship between Cerebrovascular Reactivity and Cerebral Oxygenation During Hemodialysis.
    J Am Soc Nephrol. 2022 Jul 1. pii: ASN.2021101353. doi: 10.1681/ASN.2021101353.
    PubMed     Abstract available
    
    
    
68. LASTER M, Norris KC
    Equitable Transplantation: A Modifiable Risk Factor for Disparities in Mortality in ESKD.
    J Am Soc Nephrol. 2022;33:1240-1241.
    PubMed    
    
    
    
69. BECERRA AZ, Chan KE, Eggers PW, Norton J, et al
    Transplantation Mediates Much of the Racial Disparity in Survival from Childhood-Onset Kidney Failure.
    J Am Soc Nephrol. 2022;33:1265-1275.
    PubMed     Abstract available
    
    
    June 2022
70. SILBERZWEIG J, Bhat JG, Dittrich M, Durvasula R, et al
    Collaboration between Dialysis Providers and the American Society of Nephrology: Dialysis in the COVID Pandemic.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2021111475. doi: 10.1681/ASN.2021111475.
    PubMed    
    
    
    
71. SEHGAL A, Slutzman J, Huml A
    Sources of Variation in the Carbon Footprint of Hemodialysis Treatment.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010086. doi: 10.1681/ASN.2022010086.
    PubMed     Abstract available
    
    
    
72. YUN HR, Joo YS, Kim HW, Park JT, et al
    Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010080. doi: 10.1681/ASN.2022010080.
    PubMed     Abstract available
    
    
    
73. QUINN RR, Lam NN, Ravani P, Oliver MJ, et al
    The Advancing American Kidney Health Initiative: The Challenge of Measuring Success.
    J Am Soc Nephrol. 2022;33:1060-1062.
    PubMed    
    
    
    May 2022
74. GRITTER M, Wouda R, Yeung S, Wieers M, et al
    Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 May 24. pii: ASN.2022020147. doi: 10.1681/ASN.2022020147.
    PubMed     Abstract available
    
    
    
75. PEREZ L, Biruete A
    Lack of Cultural and Language Concordant Nutrition Education for Hispanic/Latinx Individuals with Chronic Kidney Disease: A Call to Action.
    J Am Soc Nephrol. 2022 May 11. pii: ASN.2022040430. doi: 10.1681/ASN.2022040430.
    PubMed    
    
    
    
76. OKA Y, Miyazaki M, Takatsu S, Matsuda H, et al
    Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
    J Am Soc Nephrol. 2022 May 2. pii: ASN.2022030248. doi: 10.1681/ASN.2022030248.
    PubMed    
    
    
    
77. PFAU A, Knauf F
    Authors' Reply: Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
    J Am Soc Nephrol. 2022 May 2. pii: ASN.2022030359. doi: 10.1681/ASN.2022030359.
    PubMed    
    
    
    April 2022
78. RIZZOLO K, Cervantes L, Shen J
    Racial and Ethnic Disparities in Home Dialysis Use in the United States: Barriers and Solutions.
    J Am Soc Nephrol. 2022 Apr 19. pii: ASN.2022030288. doi: 10.1681/ASN.2022030288.
    PubMed    
    
    
    
79. PROVENZANO M, Puchades M, Garofalo C, Jongs N, et al
    Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial.
    J Am Soc Nephrol. 2022 Apr 19. pii: ASN.2022020207. doi: 10.1681/ASN.2022020207.
    PubMed     Abstract available
    
    
    
80. FISHBANE S, Pollock CA, El-Shahawy M, Escudero ET, et al
    Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
    J Am Soc Nephrol. 2022;33:850-866.
    PubMed     Abstract available
    
    
    
81. LOCATELLI F, Del Vecchio L
    The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease.
    J Am Soc Nephrol. 2022;33:662-664.
    PubMed    
    
    
    March 2022
82. SHANKAR S, Beckett J, Tipton T, Ogbe A, et al
    SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.
    J Am Soc Nephrol. 2022 Mar 31. pii: ASN.2021121587. doi: 10.1681/ASN.2021121587.
    PubMed    
    
    
    
83. BEETHAM KS, Coombes JS, Howden EJ
    Authors' Reply: More Research is Still Needed to Support the Real-World Generalizability of the Benefits of Lifestyle Interventions for Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 30. pii: ASN.2022030244. doi: 10.1681/ASN.2022030244.
    PubMed    
    
    
    
84. BAERMAN EA, Kaplan J, Shen JI, Winkelmayer WC, et al
    Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States.
    J Am Soc Nephrol. 2022 Mar 21. pii: ASN.2021060854. doi: 10.1681/ASN.2021060854.
    PubMed     Abstract available
    
    
    
85. VERISSIMO T, Faivre A, Rinaldi A, Lindenmeyer M, et al
    Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 10. pii: ASN.2021050680. doi: 10.1681/ASN.2021050680.
    PubMed     Abstract available
    
    
    
86. OLIVER MJ, Thomas D, Balamchi S, Ip J, et al
    Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada.
    J Am Soc Nephrol. 2022 Mar 9. pii: ASN.2021091262. doi: 10.1681/ASN.2021091262.
    PubMed     Abstract available
    
    
    
87. XU C, Smith E, Tiong M, Ruderman I, et al
    Interventions to Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
    J Am Soc Nephrol. 2022 Mar 1. pii: ASN.2021101327. doi: 10.1681/ASN.2021101327.
    PubMed     Abstract available
    
    
    February 2022
88. VLASSCHAERT C, McNaughton A, Chong M, Cook E, et al
    Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Feb 23. pii: ASN.2021060774. doi: 10.1681/ASN.2021060774.
    PubMed     Abstract available
    
    
    
89. SAEED F, Moss A, Duberstein P, Fiscella K, et al
    Enabling Patient Choice: The "Deciding Not to Decide" Option for Older Adults Facing Dialysis Decisions.
    J Am Soc Nephrol. 2022 Feb 15. pii: ASN.2021081143. doi: 10.1681/ASN.2021081143.
    PubMed    
    
    
    
90. BUNDY JD, Rahman M, Matsushita K, Jaeger BC, et al
    Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
    J Am Soc Nephrol. 2022 Feb 10. pii: ASN.2021060747. doi: 10.1681/ASN.2021060747.
    PubMed     Abstract available
    
    
    
91. BRUNELLI S, Sibbel S, Karpinski S, Marlowe G, et al
    Comparative Effectiveness of mRNA-Based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for Prevention of COVID-19 among Dialysis Patients.
    J Am Soc Nephrol. 2022 Feb 8. pii: ASN.2021101395. doi: 10.1681/ASN.2021101395.
    PubMed     Abstract available
    
    
    
92. JACOBS L, Devresse A, Baudoux T, Collart F, et al
    Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.
    J Am Soc Nephrol. 2022;33:455.
    PubMed    
    
    
    January 2022
93. LEE AM, Hu J, Xu Y, Abraham AG, et al
    Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.
    J Am Soc Nephrol. 2022 Jan 11. pii: ASN.2021040538. doi: 10.1681/ASN.2021040538.
    PubMed     Abstract available
    
    
    December 2021
94. GUO X, Xu L, Velazquez H, Chen TM, et al
    Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
    J Am Soc Nephrol. 2021 Dec 17. pii: ASN.2021040439. doi: 10.1681/ASN.2021040439.
    PubMed     Abstract available
    
    
    
95. BANSAL N, Zelnick L, Reynolds K, Harrison T, et al
    Management of Adults with Newly Diagnosed Atrial Fibrillation With and Without Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Dec 17. pii: ASN.2021060744. doi: 10.1681/ASN.2021060744.
    PubMed     Abstract available
    
    
    
96. FUKUMA S, Sasaki S, Taguri M, Goto R, et al
    Effect of Nudge-Based Intervention on Adherence to Physician Visit Recommendations and Early Health Outcomes among Individuals Identified with Chronic Kidney Disease in Screens.
    J Am Soc Nephrol. 2021 Dec 13. pii: ASN.2021050664. doi: 10.1681/ASN.2021050664.
    PubMed     Abstract available
    
    
    
97. BEETHAM K, Krishnasamy R, Stanton T, Sacre J, et al
    Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial.
    J Am Soc Nephrol. 2021 Dec 10. pii: ASN.2021050668. doi: 10.1681/ASN.2021050668.
    PubMed     Abstract available
    
    
    
98. CUKOR D, Zelnick LR, Charytan DM, Shallcross AJ, et al
    Patient Activation Measure in Dialysis-Dependent Patients in the United States.
    J Am Soc Nephrol. 2021;32:3017-3019.
    PubMed     Abstract available
    
    
    November 2021
99. SIBBEL S, McKeon K, Luo J, Wendt K, et al
    Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 Vaccines in Patients on Hemodialysis.
    J Am Soc Nephrol. 2021 Nov 17. pii: ASN.2021060778. doi: 10.1681/ASN.2021060778.
    PubMed     Abstract available
    
    
    
100. THIEME CJ, Blazquez-Navarro A, Safi L, Kaliszczyk S, et al
     Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
     J Am Soc Nephrol. 2021;32:2725-2727.
     PubMed    
     
     
     
101. GILL JS, Schold J, Kaplan B
     Understanding Risks and Our Responsibility to Living Donors.
     J Am Soc Nephrol. 2021;32:2691-2693.
     PubMed    
     
     
     October 2021
102. RUHL A, Jeffries N, Yang Y, Naik R, et al
     Alpha Globin Gene Copy Number is Associated with Prevalent Chronic Kidney Disease and Incident End-stage Kidney Disease among Black Americans.
     J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050653. doi: 10.1681/ASN.2021050653.
     PubMed     Abstract available
     
     
     
103. BUDDE K, Prashar R, Haller H, Rial M, et al
     Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial.
     J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050628. doi: 10.1681/ASN.2021050628.
     PubMed     Abstract available
     
     
     
104. HORIMOTO A, Xue D, Cai J, Lash J, et al
     Genome-Wide Admixture Mapping of Estimated Glomerular Filtration Rate and Chronic Kidney Disease Identify European and African Ancestry-of-Origin Loci in Hispanic and Latino Individuals in the United States.
     J Am Soc Nephrol. 2021 Oct 20. pii: ASN.2021050617. doi: 10.1681/ASN.2021050617.
     PubMed     Abstract available
     
     
     
105. GARCIA P, Anand S, Han J, Montez-Rath M, et al
     COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
     J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021070936. doi: 10.1681/ASN.2021070936.
     PubMed    
     
     
     
106. LIOUFAS N, Pascoe E, Hawley C, Elder G, et al
     Systematic Review and Meta-analyses of Effects of Phosphate-lowering Agents in Non-dialysis Chronic Kidney Disease.
     J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021040554. doi: 10.1681/ASN.2021040554.
     PubMed     Abstract available
     
     
     
107. NIU J, Saeed MK, Winkelmayer WC, Erickson KF, et al
     Patient Health Outcomes following Dialysis Facility Closures in the United States.
     J Am Soc Nephrol. 2021;32:2613-2621.
     PubMed     Abstract available
     
     
     
108. DANZIGER J, Mukamal KJ, Weinhandl E
     Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD.
     J Am Soc Nephrol. 2021;32:2425-2434.
     PubMed     Abstract available
     
     
     September 2021
109. VAN PRAET J, Reynders M, De Bacquer D, Viaene L, et al
     Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.
     J Am Soc Nephrol. 2021 Sep 29. pii: ASN.2021070908. doi: 10.1681/ASN.2021070908.
     PubMed     Abstract available
     
     
     
110. GO AS, Tan TC, Chertow GM, Ordonez JD, et al
     Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study.
     J Am Soc Nephrol. 2021;32:2303-2314.
     PubMed     Abstract available
     
     
     
111. BOUDHABHAY I, Delestre F, Coutance G, Gnemmi V, et al
     Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome.
     J Am Soc Nephrol. 2021;32:2362-2374.
     PubMed     Abstract available
     
     
     August 2021
112. SHEN CR, Jia XY, Luo W, Olaru F, et al
     Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease.
     J Am Soc Nephrol. 2021;32:1887-1897.
     PubMed     Abstract available
     
     
     June 2021
113. MAYRDORFER M, Liefeldt L, Wu K, Rudolph B, et al
     Exploring the Complexity of Death-Censored Kidney Allograft Failure.
     J Am Soc Nephrol. 2021;32:1513-1526.
     PubMed     Abstract available
     
     
     
114. LADIN K, Neckermann I, D'Arcangelo N, Koch-Weser S, et al
     Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives.
     J Am Soc Nephrol. 2021;32:1527-1535.
     PubMed     Abstract available
     
     
     May 2021
115. RAMSPEK CL, Evans M, Wanner C, Drechsler C, et al
     Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.
     J Am Soc Nephrol. 2021;32:1174-1186.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.